EducationSafely Reopening Derm Practices Video Series

Safely Reopening Derm Practices – Best Practices & Practical Pearls

By July 6, 2020July 7th, 2020No Comments

Dermatology News

Video Pearls

Join Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts as he discusses how the COVID-19 pandemic has affected dermatology practices across the country and around the world.

View Video Series Now

Safely Reopening Derm Practices

Best Practices & Practical Pearls

Join Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts as he discusses how the COVID-19 pandemic has affected dermatology practices across the country and around the world.  In the face of a change that no one was really prepared for, Dr. Dover and an esteemed panel of experts from the fields of Infectious Disease, Immunology, Public Health Policy, Dermatology, Plastic Surgery, and Facial Plastic Surgery, came together to render their opinions and guidance on how to safely reopen dermatology practices across the country.

This collaborative effort resulted in the publication of Project AesCert Guidance, which represents a consensus of studied principles that combines learnings from major hospital systems on the frontlines of treating COVID-19 patients¹.

In an effort to expand the reach of these and other guidelines and best practices being used by dermatology practices across the country, Dr. Dover, in partnership with the Journal of Drugs in Dermatology, invited a panel of dermatology Key Opinion Leaders to share their experience as they reopen their practices. During this 5-part video series, you will hear immediately useful pearls and best practices from Jeffrey S. Dover, MD, Nazanin Saedi, MD, Kavita Mariwalla, MD, Terrence Keaney, MD, and Thomas E. Rohrer, MD.

Watch Part I

We kick off the series with Dr. Jeffrey S. Dover. Watch as he shares pearls and best practices on:

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • PPE and Medical Supplies

View the entire video series on JDDonline.com , featuring Drs. Nazanin Saedi, MD, Kavita Mariwalla, MD, Terrence Keaney, MD, and Thomas E. Rohrer, MD.

View Video Series Now
References

1. Dover, J. S., Moran, M. L., Figueroa, J. F., Furnas, H., Vyas, J. M., Wiviott, L. D., & Karchmer, A. W. (2020). A Path to Resume Aesthetic Care: Executive Summary of Project AesCert Guidance Supplement—Practical Considerations for Aesthetic Medicine Professionals Supporting Clinic Preparedness in Response to the SARS-CoV-2 Outbreak. Facial plastic surgery & aesthetic medicine, 22(3), 125-151.

Supported in part by

You May Also Like

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Featured Articles, JDD Re:View, Latest News | No Comments
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Journal of Drugs in Dermatology JDD Article about Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

| Featured Articles, Latest News, Skin of Color | No Comments
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Journal of Drugs in Dermatology JDD Article about Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab. Image shows thumb and nail or patient.

Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab

| Case Reports, Featured Articles, Latest News | No Comments
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…

Leave a Reply